|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4985 | |
| A61K 31/5383 | |||
| A61K 31/519 | |||
| A61P 25/28 | |||
| A61P 25/18 | |||
| A61P 25/24 | |||
| A61P 25/00 | |||
| A61K 45/06 | |||
| C07D 471/14 |
| (11) | Number of the document | 3407889 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17771285.8 |
| Date of filing the European patent application | 2017-03-24 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/024137 |
| Date | 2017-03-24 |
| (87) | Number | WO 2017/165843 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 201662313629 P | 2016-03-25 | US |
| (72) |
YAO, Wei, US
LI, Peng, US
|
| (73) |
Intra-Cellular Therapies, Inc.,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
| (54) | ORGANIC COMPOUNDS AND THEIR USE IN TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS |
| ORGANIC COMPOUNDS AND THEIR USE IN TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS |